Prevenar 20 Dosage/Direction for Use

Posology: The immunisation schedules for PREVENAR 20 should be based on official recommendations.
Infants from 6 weeks to 15 months of age: It is recommended that infants who receive a first dose of PREVENAR 20 complete the vaccination course with PREVENAR 20.
Vaccination series: (See Table 13.)


Click on icon to see table/diagram/image


Pediatric population: The safety and efficacy of PREVENAR 20 in infants below 6 weeks of age have not been established. No data are available.
Special populations: There are no clinical data with PREVENAR 20 in special populations [adults and children at higher risk of pneumococcal infection including immunocompromised adults and children with human immunodeficiency virus (HIV) infection or hematopoietic stem cell transplant (HSCT), and children with sickle cell disease (SCD)].
Method of administration: For intramuscular use only.
PREVENAR 20 (0.5 mL) should be given by intramuscular injection. The preferred sites are the anterolateral aspect of the thigh (vastus lateralis muscle) in infants or the deltoid muscle of the upper arm in children and adults. PREVENAR 20 should be administered with care to avoid injection into or near nerves and blood vessels.
For instructions on the handling of the vaccine before administration, see Special precautions for disposal and other handling under Cautions for Usage.